Miller Steve's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Aug 22, 2024
- Accession no.
- 0001161697-24-000367
- Filed
- Aug 22, 2024
- Trade date
- Aug 20, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $3.05M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Miller SteveCIK 0001402535 | Officer (Chief Op. & Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 20, 2024 | Common stock, par value $0.001 per share | SSaleDisposed | −50,000 | $20.26 | −$1,013,000 | 775,124 | Direct | |
| Aug 20, 2024 | Common stock, par value $0.001 per share | SSaleDisposed | −50,000 | $20.21 | −$1,010,500 | 725,124 | Direct | |
| Aug 20, 2024 | Common stock, par value $0.001 per share | SSaleDisposed | −50,000 | $20.59 | −$1,029,500 | 675,124 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.